Synergistic impairment of glucose homeostasis in ob/ob mice lacking functional serotonin 2C receptors.
To investigate how serotonin and leptin interact in the regulation of energy balance and glucose homeostasis, we generated a genetic mouse model, the OB2C mouse, which lacks functional serotonin 2C receptors and the adipocyte hormone leptin. The OB2C mice exhibited a dramatic diabetes phenotype, evidenced by a synergistic increase in serum glucose levels and water intake. The severity of the animals' diabetes phenotype would not have been predicted from the phenotypic characterization of mice bearing mutations of either the leptin (OB mutant mice) or the serotonin 2C receptor gene (2C mutant mice). The synergistic impairment in glucose homeostasis developed at an age when OB2C mice did not differ in body weight from OB mice, suggesting that this impairment was not an indirect consequence of increased adiposity. We also demonstrated that the improvement in glucose tolerance in wild-type mice treated with the serotonin releaser and reuptake inhibitor fenfluramine was blunted in 2C mutant mice. These pharmacological and genetic findings provide evidence that the serotonin 2C receptor has direct effects on glucose homeostasis.
Wade
Jennifer M
JM
Department of Psychiatry, University of California, San Francisco, San Francisco, California 94158, USA.
Juneja
Punita
P
MacKay
Adrienne W
AW
Graham
James
J
Havel
Peter J
PJ
Tecott
Laurence H
LH
Goulding
Evan H
EH
D000818:Animals; D003920:Diabetes Mellitus / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D004195:Disease Models, Animal; D004326:Drinking / Q000502:physiology; D004435:Eating / Q000502:physiology; D005260:Female; D005277:Fenfluramine / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism*; D006706:Homeostasis / Q000502:physiology*; D007515:Islets of Langerhans / Q000473:pathology / Q000503:physiopathology; D020738:Leptin / Q000235:genetics / Q000378:metabolism*; D008297:Male; D051379:Mice; D008820:Mice, Obese; D009765:Obesity / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D044405:Receptor, Serotonin, 5-HT2C / Q000235:genetics / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D018490:Serotonin Agents / Q000494:pharmacology
D020738:Leptin; D044405:Receptor, Serotonin, 5-HT2C; D018490:Serotonin Agents; D005277:Fenfluramine; D012701:Serotonin; D005947:Glucose